Delivery Order SPE2DB25D2204-SPE2DB25FTGWC
- Not listed
- The Defense Logistics Agency awarded a $25,361.92 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.08 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on April 23, 2025, with an ultimate completion date of April 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $5,744.69 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with a completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,665.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The award, issued on June 27, 2025, with a completion date of June 30, 2025, represents a non-set-aside competitive procurement. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $18,148.02 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 16, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGWCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,581.28 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company holds a substantial $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical through December 2026, which enables delivery of a comprehensive range of pharmaceutical products and medical supplies globally. This Januvia order represents a single delivery order fulfillment under that broader contract vehicle, supporting the Defense Health Agency and other federal healthcare customers with diabetes medications and related pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 8/11/25 |